Opportunity ID: 276357

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-15-027
Funding Opportunity Title: Development and Application of Case Control Analysis for Generic Drugs (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 05, 2015
Last Updated Date: Jul 06, 2015
Original Closing Date for Applications: Jul 02, 2015
Current Closing Date for Applications: Jul 07, 2015
Archive Date: Aug 01, 2015
Estimated Total Program Funding: $200,000
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Small businesses
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Private institutions of higher education
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: The project purpose is to develop case control analysis methods that can be used in the analysis of post-market data related to generic drug substitution.
Link to Additional Information: Full Announcement of RFA-FD-15-027 on NIH Guide for Grants and Contracts
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Lisa Ko

Grants Management Specialist

Email:lisa.ko@fda.hhs.gov

Version History

Version Modification Description Updated Date
Close date has been updated to 07/07/2015. Jul 06, 2015
Jul 06, 2015

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-15-027
Funding Opportunity Title: Development and Application of Case Control Analysis for Generic Drugs (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 05, 2015
Last Updated Date: Jul 06, 2015
Original Closing Date for Applications: Jul 02, 2015
Current Closing Date for Applications: Jul 07, 2015
Archive Date: Aug 01, 2015
Estimated Total Program Funding: $200,000
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Small businesses
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Private institutions of higher education
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: The project purpose is to develop case control analysis methods that can be used in the analysis of post-market data related to generic drug substitution.
Link to Additional Information: Full Announcement of RFA-FD-15-027 on NIH Guide for Grants and Contracts
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Lisa Ko

Grants Management Specialist

Email:lisa.ko@fda.hhs.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-15-027
Funding Opportunity Title: Development and Application of Case Control Analysis for Generic Drugs (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 06, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jul 02, 2015
Archive Date: Aug 01, 2015
Estimated Total Program Funding: $200,000
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Small businesses
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Private institutions of higher education
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
For profit organizations other than small businesses
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: The project purpose is to develop case control analysis methods that can be used in the analysis of post-market data related to generic drug substitution.
Link to Additional Information: Full Announcement of RFA-FD-15-027 on NIH Guide for Grants and Contracts
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Lisa Ko

Grants Management Specialist

Email:lisa.ko@fda.hhs.gov

Folder 276357 Other Supporting Documents-SF424 R&R VersionC Instructions 1 -> sf424_rr_guide_general_adobe_verc.pdf

Packages

Agency Contact Information: Lisa Ko
Grants Management Specialist

Email: lisa.ko@fda.hhs.gov

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PKG00216666 May 15, 2015 Jul 07, 2015 View

Package 1

Mandatory forms

276357 RR_SF424_2_0-2.0.pdf

276357 PHS398_ResearchPlan_2_0-2.0.pdf

276357 PHS398_CoverPageSupplement_2_0-2.0.pdf

276357 RR_Budget_1_3-1.3.pdf

276357 RR_KeyPersonExpanded_2_0-2.0.pdf

276357 RR_OtherProjectInfo_1_3-1.3.pdf

276357 PerformanceSite_2_0-2.0.pdf

Optional forms

276357 PlannedReport-1.0.pdf

276357 PHS398_CumulativeInclusionReport-1.0.pdf

276357 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-01T06:29:25-05:00

Share This Post, Choose Your Platform!

About the Author: